tm
Seeing Is Believing
tm
Seeing Is Believing
Silverback Therapeutics's activity chart (see below) currently has 14 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 54.44% with an average time for these price targets to be met of 28 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 13-May-2022. First documented stock forecast 29-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-May-2022
$5
$-0.87 (-14.82%)
$6
4 years 5 months 20 days ago
(13-May-2022)
3/4 (75%)
$2.04 (68.92%)
121
Buy Since 29-Dec-2020
$1.8
$-4.07 (-69.34%)
4 years 7 months 1 days ago
(01-Apr-2022)
1/5 (20%)
$-1.41 (-43.93%)
1
Buy Since 29-Dec-2020
$44
4 years 7 months 1 days ago
(01-Apr-2022)
1/1 (100%)
$7 (18.92%)
2
Hold Since 01-Apr-2022
$50
4 years 7 months 1 days ago
(01-Apr-2022)
0/1 (0%)
$23.14 (86.15%)
Buy Since 29-Dec-2020
$48
$42.13 (717.72%)
$43
5 years 7 months 3 days ago
(30-Mar-2021)
1/2 (50%)
$7.43 (18.31%)
2
What is SBTX (Silverback Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SBTX (Silverback Therapeutics)?
Which analyst has the most public recommendations on SBTX (Silverback Therapeutics)?
Which analyst is the currently most bullish on SBTX (Silverback Therapeutics)?
Which analyst is the currently most reserved on SBTX (Silverback Therapeutics)?
